Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Heinzl
Low P27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy
Clinical Cancer Research
Cancer Research
Oncology
Related publications
MiR-4653-3p and Its Target Gene FRS2 Are Prognostic Biomarkers for Hormone Receptor Positive Breast Cancer Patients Receiving Tamoxifen as Adjuvant Endocrine Therapy
Oncotarget
Oncology
Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer
Breast Care
Surgery
Oncology
Adjuvant Endocrine Monotherapy for Postmenopausal Early Breast Cancer Patients With Hormone-Receptor Positive: A Systemic Review and Network Meta-Analysis
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Endometrial Thickness in Symptomatic Postmenopausal Patients Receiving Hormone Replacement Therapy or Tamoxifen
Radiographics
Medicine
Nuclear Medicine
Radiology
Imaging
The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index
British Journal of Cancer
Cancer Research
Oncology
Osteoporosis Therapy and Outcomes for Postmenopausal Patients With Hormone Receptor-Positive Breast Cancer: NCIC CTG MA.27
Cancer
Cancer Research
Oncology
Co-Expression of Estrogen Receptor Α and Apolipoprotein D in Node Positive Operable Breast Cancer – Possible Relevance for Survival and Effects of Adjuvant Tamoxifen in Postmenopausal Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Raptor Localization Predicts Prognosis and Tamoxifen Response in Estrogen Receptor-Positive Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
